Amgen (AMGN) options expected to be active after reporting Repatha data
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $374.15 +3.55%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +2.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +2.6%
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) March call option implied volatility is at 90, March weekly is at 41, April is at 26; compared to its 52-week range of 16 to 30 into releasing data for its 27,564-patient Repatha cardiovascular outcomes study,
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
- iShares Silver Trust (SLV) spreader of 5K contracts of July 90 and 100 puts
- Accelerant Holdings (ARX) 8500 contracts of July 15 calls active as share price up 8.7%
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
